[ad_1]
Speaking to Russian state television Rossiya 24, Kirill Dmitriyev, president of Russia’s Direct Investment Fund, stated that Sputnik V, the world’s first patented coronavirus vaccine developed by the Gamaleya National Research Center for Epidemiology and Microbiology , has been successfully tested and more than 12 thousand Russian citizens have been vaccinated so far. did.
“THE SCORES ARE VERY GOOD”
“More than 12 thousand people (with the first dose of the vaccine) have already been vaccinated in Russia,” Dmitriyev said. “The results are very good, the antibodies produced by our vaccine are very good, so of course the clinical trials in Russia continue to be successful,” he said.
Noting that Russia will share the results of clinical trials with other countries, Dmitriyev said: “Some will conduct clinical trials like the United Arab Emirates (UAE), and some will use data from Russia, UAE and other countries where we conduct clinical trials to approve our vaccines without clinical trials in their own countries. ” He spoke in the form.
“IT CAN BE WIDELY USED IN RUSSIA BY THE END OF THIS MONTH”
Dmitriyev stated that the Sputnik V corona virus vaccine can be widely used in Russia later this month or early November.
WHAT HAPPENED?
Developed by Gamaleya National Research Center for Epidemiology and Microbiology and produced in cooperation with RFPI, post-registration end-stage testing of the Sputnik V vaccine began in Moscow on September 7, and the first volunteers applied the vaccine for 2 days. then. The vaccine is given in 2 doses, 3 weeks apart.
It may interest you
It may interest you
It may interest you
[ad_2]
